Narrative review / 2019
Evidence for vitamin E supplementation as an effective clinical intervention in Alzheimer's disease remains limited and inconclusive.
This review evaluates the role of vitamin E in Alzheimer's disease (AD). Diminished circulating concentrations of vitamin E have been observed in individuals with AD, and reduced plasma levels have been associated with increased AD risk. Conversely, intake, particularly from dietary sources, may limit or reduce the rate of disease progression. However, randomised trials have found limited and inconsistent evidence for vitamin E supplementation as an effective intervention, and its clinical safety remains controversial.
- Study type
- Narrative review
- Who was studied
- Individuals with or at risk for Alzheimer's disease
- What was measured
- Alzheimer's disease development, progression, and treatment efficacy
THE PAPER
Vitamin E and Alzheimer's disease: what do we know so far?
Browne D, McGuinness B, Woodside JV, McKay GJ. Clin Interv Aging, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.